XML 154 R132.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Financial Statements of Parent Company - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 534,783 $ 494,308 $ 496,049
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 56,697 58,826 64,591
Share-based compensation 28,000 35,861 35,638
Decrease (increase) in other assets 5,908 (6,259) 147
(Decrease) increase in other liabilities 140,587 (6,495) (144,181)
Net cash provided by operating activities 511,960 546,757 1,730,893
Cash flows from investing activities:      
Net cash inflow from acquisitions     (250,115)
Net cash used in investing activities (886,179) (1,426,439) (4,860,396)
Cash flows from financing activities:      
Proceeds of other borrowings 4,000,000 6,050,200  
Repayment of other borrowings (4,100,000) (5,950,200) (13,000)
Common stock issuance 3,237 2,772 2,858
Common stock repurchased (16,758) (16,064) (119,330)
Dividends paid on common stock (162,894) (156,184) (146,664)
Stock options exercised 5,580 2,926 1,585
Net cash provided by (used in) financing activities 767,409 565,996 (2,279,505)
Net increase (decrease) in cash and cash equivalents 393,190 (313,686) (5,409,008)
Cash and cash equivalents at beginning of period 998,877 1,312,563 6,721,571
Cash and cash equivalents at end of period 1,392,067 998,877 1,312,563
Parent company | Reportable Legal Entities      
Cash flows from operating activities:      
Net income 534,783 494,308 496,049
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization (371) (371) (208)
Share-based compensation 28,000 35,861 35,638
Decrease (increase) in other assets (1,398) 2,539 (375)
(Decrease) increase in other liabilities 2,104 175 (243)
Undistributed earnings of subsidiaries (397,416) (345,030) (299,858)
Net cash provided by operating activities 165,702 187,482 231,003
Cash flows from investing activities:      
Net cash inflow from acquisitions     51,566
Net cash used in investing activities     51,566
Cash flows from financing activities:      
Proceeds of other borrowings 100 100  
Repayment of other borrowings (100) (100) (13,000)
Common stock issuance 3,237 2,772 2,858
Common stock repurchased (16,758) (16,064) (119,330)
Dividends paid on common stock (162,894) (156,184) (146,664)
Stock options exercised 5,580 2,926 1,585
Net cash provided by (used in) financing activities (170,835) (166,550) (274,551)
Net increase (decrease) in cash and cash equivalents (5,133) 20,932 8,018
Cash and cash equivalents at beginning of period 110,001 89,069 81,051
Cash and cash equivalents at end of period $ 104,868 $ 110,001 $ 89,069